St. Louis Venture Capital

St. Louis Venture Capital

St. Louis: A Place for Entrepreneurs
and Investors (Video)

The St. Louis biotech industry is attracting the interest of venture capitalists from around the world. The area is home to 14 venture capital funds with over $1 billion under management, half of which is dedicated to biotech.

Reflecting the opportunities in the region, two venture capital firms — Prolog Ventures and Oakwood Medical Investors — raised new funds in the biotech sector. In addition, an $81.5 million fund-of-funds, Vectis Medical Sciences Fund I, began making investments in medical science venture capital funds with ties to the region.

To complement the area's venture capital resources, the St. Louis Arch Angels was established in January 2005. Arch Angel members provide early-stage capital in range of $2 million, an investment range not generally served by VCs.

Now in its third year, the International Agriculture Innovation Showcase at the Bio-Research & Development Growth (BRDG) Park at the Danforth Plant Science Center presents an opportunity to discuss the importance of funding new agribusiness in the current financial climate. Many venture capitalists from around the country praised the St. Louis region as a place of opportunity for companies prepared to take research to the commercial marketplace. To view the video "Venture Capitalists Applaud St. Louis" and many others created by BRDG Park, click here.

Venture Capital Firms Include:

St. Louis-Based Seed Capital Funds:

The St. Louis Capital Alliance was formed by the St. Louis RCGA in 2005 to help develop a more vibrant capital environment in Greater St. Louis. To learn more about the Capital Alliance, click here.